County-level variation in cardioprotective antihyperglycemic prescribing among medicare beneficiaries

Background: Cardioprotective antihyperglycemic agents, SGLT2 inhibitors (SGLT2i) and GLP-1 receptor agonists (GLP1RA), improve outcomes of patients with type 2 diabetes, but adoption has been limited. Differences across individuals have been noted but area-level variation is unknown. Objectives: Giv...

Full description

Bibliographic Details
Main Authors: Jonathan Hanna, Arash A Nargesi, Utibe R. Essien, Veer Sangha, Zhenqiu Lin, Harlan M Krumholz, Rohan Khera
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:American Journal of Preventive Cardiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S266666772200054X